Related Experiment Video
Updated: Apr 9, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
Patient participation in a Clinical Guideline Development for Systemic Lupus Erythematosus
Pedro Serrano-Aguilar1, Maria del Mar Trujillo-Martin2, Abraham Pérez de la Rosa3
1Evaluation Service of the Canary Islands Health Service (SESCS), Santa Cruz de Tenerife, Spain; Spanish Network of Health Services Research for Chronic Diseases (REDISSEC), Madrid, Spain.
Objective:
To incorporate patients' perspective in the design of a clinical practice guideline (CPG) for Systemic Lupus Erythematosus in Spain.
Methods:
A systematic review (SR) of literature and a Delphi-based consultation to patients were carried out.
Results:
From the SR, most relevant health problems are classified as physical, psychological, familial, and socio-economic. Dissatisfaction is mainly due to unmet information needs and limited access to care. In the consultation (n=102), most frequently reported health problems were pain, fatigue, photosensitivity, mood disorders, renal damage, poor concentration, and memory loss. Dissatisfaction with poor coordination between primary and specialized care was reported. Information to improve self-management and on alternative therapies was requested. Relevant topics from both sources were merged and discussed by the guideline development group (including a patient representative) to set the key questions underpinning the CPG.
Conclusion:
Patient involvement in CPG development by a combination of methods can enhance patient-centered care by achieving clinical practice responsive to their needs.
Practice Implications:
Involving patients in CPG development is feasible and useful to improve the advance of Health Services toward patient-centered care. A multicomponent strategy for involvement is suggested to address the gap between the available evidence and contextual current patient needs and preferences.
More Related Videos
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Rheumatic Heart Disease III: Medical Management
Nephrotic Syndrome III : Nursing Management
Rheumatic Heart Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

